Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Avicena
AddedFeb 16, 2024
UpdatedJun 18, 2026
Avicena

Avicena

Pre-Seed

Avicena: Innovating cardiovascular health with advanced medical devices and algorithms.

HQ
Pasadena, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize cardiovascular health, Avicena develops advanced medical devices and algorithms designed to easily assess cardiovascular conditions. Their flagship product, Vivio®, offers a mobile, non-invasive approach to diagnosing cardiovascular diseases, making it accessible across various care settings. Avicena aims to improve patient outcomes through rapid and accurate health assessments, targeting both healthcare providers and patients in need of efficient cardiovascular diagnostics.

Avicena has attracted notable investors and affiliations within the medical technology sector, bolstering its credibility and reach. The company has achieved significant milestones, including the successful deployment of Vivio® in multiple healthcare environments, demonstrating its practical utility and effectiveness. Through its innovative solutions, Avicena is making a substantial impact on the early detection and management of cardiovascular diseases, contributing to better health outcomes on a global scale.

Avicena - Similar Companies

InvisionHeart logo

InvisionHeart

invisionheart.com

Aviir logo

Aviir

aviir.com

Avidhrt logo

Avidhrt

avidhrt.com

AliveCor logo

AliveCor

alivecor.com

Vital Metrix logo

Vital Metrix

Cardiac Insight logo

Cardiac Insight

Avive Solutions logo

Avive Solutions

avive.life

Avacen Medical logo

Avacen Medical

avacen.com

Avinger logo

Avinger

avinger.com

InnoVein logo

InnoVein

Dynocardia logo

Dynocardia

dynocardia.care

VerAvanti logo

VerAvanti

veravanti.com

Vixiar Medical logo

Vixiar Medical

vixiar.com

InVision Medical Technology logo

InVision Medical Technology

Evident Vascular logo

Evident Vascular

Avicena - Quick Facts

Who are Avicena's competitors?

Companies similar to Avicena include InvisionHeart, Aviir, Avidhrt and AliveCor.

When was Avicena founded?

Avicena was founded in 2014.

Where is Avicena's headquarters located?

Avicena's headquarters is located in Pasadena, CA, US.

When was Avicena's last funding round?

Avicena's most recent funding round was for $573k (USD) in July 2017.

How much has Avicena raised to-date?

As of Jul 28, 2017, Avicena has raised a total of $2.5M (USD).

How many employees does Avicena have?

Avicena has 24 employees as of Feb 4, 2024.

Avicena - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified